| scholarly article | Q13442814 |
| P50 | author | Sebastian Aguiar Brunemeier | Q59176422 |
| Marten P Smidt | Q59551353 | ||
| P2093 | author name string | Lars P van der Heide | |
| Lars von Oerthel | |||
| Willemieke M Kouwenhoven | |||
| Dorinde S Starmans | |||
| Edward J Robinson | |||
| P2860 | cites work | Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis | Q24306444 |
| MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2 | Q24563123 | ||
| Specification of dopaminergic subsets involves interplay of En1 and Pitx3 | Q28593766 | ||
| Parkinson's disease: mechanisms and models | Q29547424 | ||
| ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor | Q29616727 | ||
| A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo | Q34241381 | ||
| SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction | Q34788849 | ||
| Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease | Q35157431 | ||
| Mcl-1 deficiency results in peri-implantation embryonic lethality | Q35185567 | ||
| The BCL-2 family reunion | Q35568029 | ||
| Myeloid cell leukemia 1 (Mcl(-1)) protects against 1-methyl-4-phenylpyridinium ion (MPP+) induced apoptosis in Parkinson's disease | Q35743031 | ||
| Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization | Q35857019 | ||
| The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax | Q35925042 | ||
| Trim17-mediated ubiquitination and degradation of Mcl-1 initiate apoptosis in neurons | Q36560455 | ||
| Programmed cell death in Parkinson's disease | Q38036233 | ||
| The secrets of the Bcl-2 family | Q38039293 | ||
| Small molecule Mcl-1 inhibitors for the treatment of cancer | Q38244767 | ||
| Parkin sensitizes toward apoptosis induced by mitochondrial depolarization through promoting degradation of Mcl-1. | Q38934057 | ||
| Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. | Q39696436 | ||
| Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival | Q39761203 | ||
| Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons | Q40592671 | ||
| Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons | Q42322825 | ||
| Genome wide expression profiling of the mesodiencephalic region identifies novel factors involved in early and late dopaminergic development | Q42356632 | ||
| Retinoic acid-dependent and -independent gene-regulatory pathways of Pitx3 in meso-diencephalic dopaminergic neurons | Q43564367 | ||
| The BCL2 code to dopaminergic development and Parkinson's disease. | Q46444138 | ||
| Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice | Q47381832 | ||
| Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors | Q48240262 | ||
| Pre-administration of BAX-inhibiting peptides decrease the loss of the nigral dopaminergic neurons in rats. | Q52145827 | ||
| Developmental cell death in dopaminergic neurons of the substantia nigra of mice. | Q52166629 | ||
| Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. | Q54679983 | ||
| Involvement of the bcl-2 gene in human follicular lymphoma | Q69870224 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| P304 | page(s) | 107 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Cell Death Discovery | Q27726740 |
| P1476 | title | Survival of midbrain dopamine neurons depends on the Bcl2 factor Mcl1 | |
| P478 | volume | 4 |
| Q104795238 | Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities | cites work | P2860 |
Search more.